dipeptide derivativeNootropic Peptides

Noopept (GVS-111)

A synthetic dipeptide-derived nootropic (N-phenylacetyl-L-prolylglycine ethyl ester). Not technically a peptide but a peptide-derived small molecule. Increases BDNF and NGF. Approved in Russia for cognitive disorders.

cognitive-enhancementBDNF-increaseNGF-increaseneuroprotectiveoral-bioavailability
3D Structure
3D Structure
318.37 Da
45 atoms
Molecular Weight318.37 Da
FormulaC17H22N2O4
PubChem CID180496
Lab Tested
No
Harmful Ingredients
0
Contaminants
None
Tested Purity
--
Batch Consistency
No batch data
Mass Spec Profile
Intensity160205251296341m/z319.2
ESI-MS (computed)
Batch Info
Latest Batch
Total Tests0
Unique Vendors0
Vendor Comparison
No vendor data yet
Analysis Summary
Purity Standard
No purity data
Lab Reports
0 reports on file
Summary

A synthetic dipeptide-derived nootropic (N-phenylacetyl-L-prolylglycine ethyl ester). Not technically a peptide but a peptide-derived small molecule. Increases BDNF and NGF. Approved in Russia for cog…